http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103524759-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08H1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F289-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F222-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J3-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F220-06 |
| filingDate | 2013-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103524759-B |
| titleOfInvention | The preparation method of animal ceratin based high molecular hydrogel and the application as pharmaceutical carrier |
| abstract | The invention provides a kind of preparation method of animal ceratin based high molecular hydrogel, after animal ceratin is scattered in urea or sodium hydroxide solution, with dithiothreitol (DTT) or mercaptoethanol for reductive agent reduces, then with N, N '-methylene-bisacrylamide is linking agent, makes animal ceratin and methacrylic acid carry out being polymerized and obtain.Experiment shows, animal ceratin based high molecular hydrogel prepared by the present invention has good swelling and deswelling performance, and has pH susceptibility, has slow release effect well to small molecule model medicine, therefore can be used as the production of pharmaceutical carrier for pharmaceutical preparation. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107158752-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107158752-B |
| priorityDate | 2013-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.